Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.48
-0.83 (-6.24%)
May 7, 2026, 4:08 PM HKT

HKG:2591 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Net Income
-341.36-174.69-733.38
Depreciation & Amortization
9.416.7619.54
Other Amortization
0.580.170.1
Loss (Gain) From Sale of Assets
-0.3-
Loss (Gain) From Sale of Investments
--0.19-1.13
Stock-Based Compensation
14.9616.04538.9
Other Operating Activities
-1.59-12.58-8.43
Change in Accounts Receivable
-5.56--
Change in Inventory
-86.91-25.590.23
Change in Accounts Payable
134.042.7115.64
Change in Other Net Operating Assets
-19.0914.463.92
Operating Cash Flow
-295.54-162.62-164.6
Capital Expenditures
-19.97-3.95-12.05
Sale (Purchase) of Intangibles
-2.06-0.38-0.15
Investment in Securities
44.66280.28-145.02
Investing Cash Flow
22.63275.95-157.21
Short-Term Debt Issued
172.769.91
Total Debt Issued
172.769.91
Short-Term Debt Repaid
-32.4-1-1
Long-Term Debt Repaid
-1.91-0.81-4.45
Total Debt Repaid
-34.31-1.81-5.45
Net Debt Issued (Repaid)
138.458.1-4.45
Issuance of Common Stock
621.78250367.81
Other Financing Activities
-37.87-3.26-11.66
Financing Cash Flow
722.37254.84351.71
Foreign Exchange Rate Adjustments
-6.890.70.71
Net Cash Flow
442.58368.8730.61
Free Cash Flow
-315.51-166.57-176.64
Free Cash Flow Margin
-239.91%--
Free Cash Flow Per Share
-0.73-0.40-0.46
Cash Interest Paid
1.720.872.32
Levered Free Cash Flow
-224.14-95.73-
Unlevered Free Cash Flow
-223.06-95.18-
Change in Working Capital
22.48-8.4119.79
Source: S&P Global Market Intelligence. Standard template. Financial Sources.